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Introduction
Synthetic particles are a popular class of vectors for nucleic acid delivery. With the emergence of advanced synthetic techniques, these particles can be engineered to facilitate non-viral nucleic acid delivery, targeting, cellular uptake and release. [1] [2] [3] Polymeric particles are attractive materials for such purposes. These structures can be built from the corresponding polymeric components in order to attain the desired properties and functionalities, such as particle size, charge, morphology and surface chemistry. [4] [5] [6] [7] Surfactant-free reversible addition-fragmentation chain transfer (RAFT) emulsion polymerisation technique is an advantageous method to synthesise latex particles for potential bioapplications, [8] [9] [10] since this approach does not required the use of particle-stabilising surfactants, which may desorb from particles overtime and hampered therapeutic applications. 11 To act as particle stabiliser in the preparation of latex particles by surfactantfree RAFT emulsion polymerisation, two strategies have already been employed: the use of surface-active amphiphilic RAFT-capped block copolymers, [12] [13] [14] [15] [16] or a one-pot polymerisation of a hydrophobic monomer from a low molar mass surface-active RAFT agent. 17 While the particles formation kinetics and their morphology control have been studied extensively, there are only a few scarce examples describing the use of this technique to engineer latex particles for the attachment of biomolecules or therapeutic agents. The most noteworthy examples to date are the work of Stenzel and co-workers, who prepared glucose-stabilised polystyrene latex particles as anti-infection agents, 18 and that of Wang and co-workers, who prepared poly(2-(dimethylamino)ethyl methacrylate)-stabilised redox-sensitive polystyrene latex particles as hydrophobic drug carrier. 19 In this contribution, we demonstrate the synthesis of polystyrene (PS) latex particles as microRNA delivery vectors via surfactant-free RAFT emulsion polymerisation, using polyacrylamide (PAAm) as a particle steric stabiliser. On one hand, PS was chosen as the core-forming block for the particles since this inert material is suitable for a diverse range of biological applications. 20 For instance, PS nanoparticles have been used for modelling the interactions of serum protein-nanoparticle complexes with cells. 21 Moreover, PS-based microspheres/microbeads have been employed for cell separation, immunoassays, drug delivery studies and biological imaging. 22 PAAm, on the other hand, is an attractive polymer because of its high solubility in aqueous media, its low susceptibility to hydrolysis at neutral pH and is non-toxicity. [23] [24] [25] It is also recognised as a potential material for therapeutic delivery and conjugation to genetic materials. For instance, Martínez-Ruvalcaba et al. prepared PAAm nanoparticle-based acrylic acid/chitosan hydrogel as a drug delivery model and studied its controlled release properties of ascorbic acid. 26 Maeda and co-workers demonstrated the successful conjugation of PAAm to single-stranded DNA for measuring the genetic variations between individuals of a species. 27 More recently, PAAm-stabilised iron oxide nanoparticles have been developed for the delivery of chemotherapy drugs into a solid tumour model. 28 The synthesis of PAAm-stabilised PS latex particles has previously been reported by Xie and co-workers, who copolymerised styrene monomer droplets dispersed in aqueous phase with PAAm macro-RAFT agent to form 58 nm latex particles in situ. 29 Herein, we have designed a different surfactant-free RAFT emulsion polymerisation approach to prepare more uniform and smaller sized (11 nm) carboxyl-a-end HOOC-PAAm-stabilised PS latex particles, using pre-formed HOOC-polyacrylamide-block-polystyrene (HOOC-PAAm-b-PS) copolymer micelles as latex particle precursors. The use of an amphiphilic macro-RAFT agent permits to seed the particle formation and enables greater control over both the particle size, down to ca 10nm, and their size distribution, both of which are key to most bioapplications of nanoparticles as delivery vectors. We have used miR-200b duplex as model microRNA (miRNA) payload to illustrate the ability of the particle to carry and deliver an active agent.
miR-200b has been shown to suppress epithelial-mesenchymal transition in human renal proximal tubular cells by decreasing the production of fibronectin-one of the major proteins involved in fibrosis when abundantly expressed. 30 The size of nanoparticles is particularly relevant to the delivery of miR-200b, as it is targeted to human renal proximal tubular cells, a delivery process that is particularly known for requiring small delivery vectors. Indeed, delivery to human renal proximal tubular cells occurs through the glomerular filtration system, which is known to only allow through small particles, with a known cutoff of 14 nm, established by following protein pathways. 31 The conjugation of the miRNA duplex to the particles was achieved by first post-polymerisation functionalisation of the carboxyl-a-end functional particles with a bioreducible disulfide ligand 2-(2-pyridyldithio)ethylamine (PDE), followed by coupling to the thiol terminal group of the miRNA (Scheme 1). Scheme 1. Schematic summary of the particle engineering for miRNA conjugation: HOOCPAAm-stabilised PS latex particle synthesis, post-polymerisation functionalisation with 2-(2-pyridyldithio)ethylamine linker and conjugation to miRNA. Transmission electron microscopy (TEM). PS nanoparticles were observed using transmission electron microscope (Philips CM120 Biofilter, accelerating voltage 120 kV).
Experimental
Particle samples were diluted in water and the dispersion was drop-cast onto a 400 meshedcopper TEM grid. The grid has been coated with Formvar™, which was covered by a 10 nm carbon layer. Solvents from the sample on the TEM grid were evaporated before imaging under TEM. . Solids content of particles after dialysis was established to be 0.37%. Size and dispersity of PS latex particles were obtained from DLS and HDC. The latex particles were also studied by TEM.
Ultraviolet-visible (UV-
PS latex particle stability in freeze-thaw cycles. PS latex particles were frozen by dry ice for an hour, followed by thawing at room temperature. The freeze-thaw procedure was repeated 10 times and the PSD of latex was monitored by DLS at the end of each thawing. CTAs. These side reactions include hydrolysis of the monomer to form ammonia, which causes unwanted aminolysis of the CTAs, slow polymerisation rate and poor monomer conversion (< 28%). [35] [36] [37] Aiming to minimise such side reactions, we opted for a trithiocarbonate CTA, PABTC, to mediate the polymerization, as it has better hydrolytic stability even at temperatures as high as 70 °C, 24 and the polymerisations were undertaken in 40% in volume dioxane, in order to limit AAm hydrolysis. Furthermore, dioxane also facilitates the solubilisation of both PABTC and styrene monomer at the chain extension Conversion and DP of styrene were determined from 1 H-NMR in situ ( Figure S4 ). Comparing the integration of the aromatic protons of PS backbone with the vinyl peaks of the styrene monomer at 5.81 ppm gave 88% monomer conversion, equivalent to a styrene DP around 8.
Synthesis of 2-(2-pyridyldithio)ethylamine (PDE) linker. 2-(2-
Unfortunately, the diblock copolymer HOOC-PAAm 14 -b-PS 8 could not be analysed by size exclusion chromatography and ESI-MS due to its poor solubility.
Preparation of PS latex particles stabilised by PAAm. PS latex particles stabilised by
PAAm were prepared via surfactant-free RAFT emulsion polymerisation. This involved the self-assembly of HOOC-PAAm 14 -b-PS 8 diblock copolymer into polymeric micelles, followed by chain-extending the hydrophobic block within the micelle cores with additional styrene monomer. Dioxane was added to the solution as a co-solvent for the self-assembly of PAAmb-PS, as it enables better mobility of the glassy PS block. 39 Micellization was performed by first adding the crude HOOC-PAAm 14 -b-PS 8 diblock mixture to an aqueous NaOH solution,
followed by slow addition of water with constant stirring. NaOH deprotonates the carboxylic acid group at the chain end of the macroRAFT surfactant, thus promoting ionisation between PAAm chains for micelization. It is noteworthy that attempts to form micelle in absence of NaOH were unsuccessful. Upon addition of water to the copolymer solution, the hydrophobic styrene block aggregated into micelle cores along with the butyl trithiocarbonate end group; the hydrophilic PAAm block and the carboxylic acid moiety became the coronas of the micelles and extended in the aqueous environment. The micelle solution was observed to be clear throughout the addition of water, indicating the micelles were well dispersed in the water phase. The size distribution of the micelles was confirmed by DLS. Figure 1 shows the micelles having an average size of 9.3 nm in diameter, with a particle size distribution (PSD) of 0.216. It is noteworthy that the approximate micelle radius (4. (Table 1) . DLS confirmed these observations, and TEM images ( Figure   3 ) reveal the particles are spherical in shape and also confirmed a fairly uniform size. The observed particle morphology correlated with the structure of their precursor micelles formed by PAAm 14 -b-PS 8 copolymers was suggested to be spherical from DLS ( Figure 1) as discussed above. TEM results also supported that chain-extension of the diblock macro-RAFT agents with styrene was carried out within the loci of spherical micelles, which have been evolved into spherical particles. Table 1 summarises the sizes of particles obtained from different techniques. Diameters of the particles measured from DLS were in good agreement with the results obtained from HDC. The overall particle diameters estimated from TEM appeared to be smaller compared to DLS and HDC measurements as anticipated, since TEM only images the electron-rich PS core of the particles. The PAAm chains at the particle corona, on the other hand, were not electron-dense enough to be observed under the electron microscope without staining. Furthermore, the PS chains at the particle cores were expected to collapse when the latex particles were dehydrated during TEM sample preparation. In addition to the water evaporation process, electron bean irradiation during TEM imaging could also cause the particles to shrink from their original dimensions. Stability of PS latex particles. Stability of the PS latex particles is critical to their use in bioapplications, as they have to survive the process that engineers delivery vectors. Stability can be assessed theoretically by knowing the particles surface area coverage. Assuming each of the particle-forming -OOC-PAAm-b-PS copolymer was 100% chain-extended from HOOC-PAAm chains, the PS core surface area occupied by each steric stabiliser (i.e. PAAm chain) would be equivalent to the area covered by each -OOC-PAAm-b-PS copolymer chains.
Each latex particle core was calculated to be covered by an average of 113 polymer chains, where individual polymer chain was estimated to occupy 1.6 nm 2 of the surface area of the PS core (see ESI for calculations). The average surface area of particle core occupied by each polymer chain was fairly small, suggesting strong sterical stabilization. This steric stability was tested by multiple freeze-thaw cycles, which involved freezing the particle by dry ice at -78.5 °C for an hour, followed by thawing at room temperature -such a process mimics the conditions of storage for delivery vectors. The PSD of the thawed latex was monitored by DLS at the end of each freeze-thaw cycle to detect the presence of aggregates, indicators of unstable particles. The DLS traces in Figure 4 illustrates that no large aggregates were present in the latex during the first five freeze-thaw cycles, indicating the particles remained stable during the freezing process. Starting from the sixth cycle, noticeable amounts of aggregates were detected by DLS. The presence of these aggregates gave rise to PSD of latex from 0.2 to 0.35. The diameter of the particles was observed to increase by approximately 2 nm from the second freeze-thaw cycles. Nevertheless, the particles still demonstrated a good steric stability as major population observed on DLS remained consistent throughout the freeze-thaw cycles.
This suggested the average amount of stabilisers on each particle was sufficient to provide good steric stabilisation for the latex in the aqueous dispersed media. 
Intensity (%)
Cycle 10 thiol-disulfide exchange between PDE linkers on particles and thiol-modified miRNA. This synthetic route was considered to be much cleaner than conjugation in the reversed order as fewer intermediates and side-products would be involved during miRNA attachment.
Conjugation of PDE linker to the latex particles was carried out via EDC/NHS coupling.
Aiming to modify 20% of the carboxylate groups on the particle surface, the conjugation was carried out by reacting with 0.2 equivalents PDE in the presence of 12 equivalents EDC and 24 equivalents NHS. The conjugation was carried out in 2-(N-morpholino)ethanesulfonic acid (MES) buffer at pH 5.65. The use of MES buffer was necessary to maintain the workable pH range for carboxylate activation with EDC. The buffer pH in the activation step, however, was slightly lower than the optimal pH range (pH 6-9) for carboxylic acid esterification with NHS. 43, 44 This condition could prevent complete esterification of the carboxylic acid groups on the particle surface in order to retain the particle stability in water. The amidation was carried out overnight, followed by dialysis to remove unconjugated PDE linkers and byproducts from the latex. The modified particles were then treated with reducing agent tris(2-carboxyethyl)phosphine (TCEP) to quantify the amount of PDE loading through the release of pyridinethione, which absorbs at 342 nm. 33 Figure 5 illustrates the UV-Vis spectra of the PDE-loaded PS latex particles during the course of TCEP treatment. The characteristics absorption peak at 310 nm corresponds to the RAFT thiocarbonylthio group on the particles. 45 The slight increase in absorbance at 310 nm was attributed to the release of pyridinethione, which also contributed to the growth of absorbance at 342 nm. The thiocarbonylthio signal did not show any shift of the maximum absorption, indicating the trithiocarbonate groups on the particles remained intact in the presence of TCEP overtime. 46 The PDE conjugation efficiency was calculated to be 19 ± 3.7 %. On average, each particle was functionalised with 4-5 molecules of PDE linkers on the surface. The miRNA model for conjugating to the PS latex particles was a 23-nucleotide long duplex, miR-200b. This miRNA is associated with the decrease in the production of fibronectin, which plays a key role in the development of fibrosis when upregulated. 30 It is anticipated that fibrosis can potentially be treated through therapeutic delivery of miR-200b. Using a duplex is key to the stability of the miRNA, as the incorporation of complementary strand prolonges its intracellular stability when delivered in vitro and in vivo. 47 The duplex structure can protect the miRNA from pre-mature degradation by ubiquitous endogenous ribonucleases (RNases) prior to loading onto the RNA-induced silencing complex (RISC) in the RNA interference (RNAi) pathway. 48 The 5'-phosphate group of the sense strand, which carried the target miR- 200b to the PDE-modified latex particles at room temperature. The particles, each of which carried at least 4 molecules of PDE linkers on average, reacted with 3 copies of miRNA. The conjugation was followed by UV-Vis and successful miRNA attachment was evident by the increase in absorbance at 342 nm due to the release of pyridinethione. The reaction was stopped after 4 hours when the pyridinethione absorbance became constant. The conjugation proceeded with 86 ± 13% efficiency, which suggested every particle was functionalised with 2-3 copies of miR-200b. The conjugation efficiency was also determined via measuring the UV-Vis absorbance of miRNA nucleobases at 260 nm. 49 The miRNA-conjugated PS latex particles were washed by ultrafiltration multiple times to remove unreacted miRNA and pyridinethione. At the end of each wash, the UV-Vis absorbance of the purified particles in the retentate was taken along with the filtrate. Two strong absorption peaks of miRNA nucleobases at 260 nm and RAFT thiocarbonylthio groups on particles at 310 nm were observed from the retentates after each wash ( Figure 6a) . The 260 nm peak shows a gradual decrease in the absorbance due to the removal of unattached miRNA after washing.
Nevertheless, the retentate still presented a strong absorbance at 260 nm after five washes, confirming the successful attachment of the nucleic acid to the particles. The free miRNA washed out gave rise to the strong absorbance at 260 nm of the filtrate (Figure 6b ). This signal decreased to a low absorbance after the fifth wash, demonstrating most of the unreacted miRNA has been removed. Along with the miRNA signal, the pyridinethione absorption peak at 342 nm was also observed from the filtrate collected after the first wash. The appearance of pyridinethione provided strong evidence for the conjugation to occur via thiol-disulfide exchange. The conjugation efficiency was determined from the loss of miRNA in the retentate after the fifth wash and the total amount of miRNA collected in the filtrates. The efficiency calculated from the retentate was 72%, which is close to the value determined from the pyridinethione absorbance within the estimated error. The conjugation efficiency estimated from the filtrate was found to be 83%, which was similar to the efficiency determined from the pyridinethione approach. 
(b) (a)
Glutathione-triggered miRNA release from miRNA-nanoparticle conjugates. The ability to reduce the disulfide-bridges between the particles and the miRNA was tested with glutathione (GSH). In mammalian cells, the intracellular GSH level ranges between 0.5 mM and 10 mM, which is 1000-fold more concentrated than the extracellular level. 46, 50 Previous studies have demonstrated the slow release of therapeutic agents when the cleavable disulfidecontaining vectors were incubated at extracellular GSH concentrations. Near-complete release of the therapeutic agent was achieved within 1 hour when the GSH concentration was increased to the maximum intracellular level. [51] [52] [53] Aiming to investigate if the releasing mechanism is as rapid in our system, we incubated the miRNA-nanoparticle conjugates with 
Conclusions
We have demonstrated the successful synthesis of amphiphilic HOOC-PAAm 14 -b-PS 8 diblock copolymer mediated by RAFT polymerisation. The diblock copolymer was able to selfassemble into polymeric micelles for the preparation of 11 nm -OOC-PAAm-stabilised latex nanoparticles via surfactant-free RAFT emulsion polymerisation. These particles exhibited narrow size distributions as confirmed by DLS, HDC and TEM. Each latex particle core was covered by an average of 113 polymer chains; where individual polymer chain was estimated to occupy 1.6 nm 2 of the surface area of the PS core. The small particle surface area occupied by each polymer chain suggested the particles were well sterically stabilised. Steric accumulation. The efficiency of the process permit to avoid any residual monomer remain in the colloids, thus avoiding toxicity issues. Beyond drug delivery, we also envision these nanoparticles could be further use, for instance for imaging and diagnostic applications.
Supporting information.
1 H NMR and ESI-MS characterisation of macro-RAFT agent, calculation details of livingness of macro-RAT agent, calculation of surface coverage of PS latex particles, 1H NMR characterisation of PDE linker and pyridinethione.
